Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01446653 · ClinicalTrials.gov registry record · NA

Reducing Alcohol Exposed Pregnancy Risk: EARLY Randomized Controlled Trial

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
232
Enrollment target

NCT01446653: Completed NA study, sponsored by University of Virginia.

NCT01446653 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 232 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01446653, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
232 participants
Enrollment target

Study Summary

The EARLY Randomized Controlled Trial (RCT) will test the finalized EARLY preventive intervention against one comparison and one control condition. Because prevention of Alcohol-exposed pregnancy (AEP) will be achieved whether woman change drinking OR contraception, the primary endpoints will be rates of risky drinking and ineffective contraception at six-month follow-up, in addition to dichotomously defined "successful outcome" that will be observed whenever a woman has sufficiently altered one or both of the behaviors that placed her at risk of Alcohol-Exposed Pregnancy (AEP). The goal is to identify a transferable intervention that effectively reduces behaviors that put women at risk for AEP and alcohol-related birth defects including FASD.

Interventions

  • BEHAVIORAL Video
  • BEHAVIORAL Informational Brochure
  • BEHAVIORAL Motivational Interviewing plus feedback

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2007-02
Est. Completion 2011-09
Phase NA
University of Virginia

449 total trials

What the finished NCT01446653 record still lists

NCT01446653 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 3 interventions - of which Video is the first listed.

NCT01446653 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01446653 about?

NCT01446653 is a clinical study titled "Reducing Alcohol Exposed Pregnancy Risk: EARLY Randomized Controlled Trial". The EARLY Randomized Controlled Trial (RCT) will test the finalized EARLY preventive intervention against one comparison and one control condition. Because prevention of Alcohol-exposed pregnancy (AEP) will be achieved whether woman change drinking OR contraception, the primary endpoints will be rat...

What is the current status of trial NCT01446653?

This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2007-02. Estimated completion is 2011-09.

What interventions are being tested in trial NCT01446653?

The interventions under investigation include: Video (BEHAVIORAL), Informational Brochure (BEHAVIORAL), Motivational Interviewing plus feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT01446653?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01446653's enrollment target sits among peer trials

232 463rd of 2000 higher than 1,536 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01356290 · 232 participants · Phase 2

    Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

  • NCT04753359 · 232 participants · NA

    Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer

  • NCT04770870 · 232 participants · NA

    Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System

  • NCT05948943 · 232 participants · Phase 2

    Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01446653, the US trial registry maintained by the National Library of Medicine. NCT01446653 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.